MRK

Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum — Vice President, Investor…

Merck & Co Inc (NYSE:MRK) Q4 2022 Earnings Call dated Feb. 02, 2023. Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations…

Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income…

Merck & Co Inc (NYSE:MRK) Q3 2022 Earnings Call dated Oct. 27, 2022. Corporate Participants: Peter Dannenbaum — Vice President of Investor…

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line…

Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The…

Merck & Co., Inc. (NYSE: MRK) Q1 2022 Earnings Conference

Merck & Co. Inc.  (NYSE: MRK) Q1 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Peter Dannenbaum — Vice President of…

Merck & Co., Inc.  (NYSE: MRK) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Peter Dannenbaum — Vice President of…